Sirius Medical, a surgical marker navigation company from Eindhoven, the Netherlands, closed a Series B Round of \u20ac12 Million. The funding aims to accelerate the worldwide growth of their product Pintuition and support further product development. Holland Capital was the lead investor for this series B with support from existing investors BOM Brabant Ventures, Curie Capital, Team Holmium, and Sirius Medical\u2019s management and team. Norgine Ventures joined as a new investor in this round to support the further commercial roll-out.<\/p>\n\n\n\n
With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of affordable solutions that enable precise and efficient removal of tumors. The Pintuition technology is both CE-marked and FDA-cleared.\u00a0<\/p>\n\n\n\n
Sirius\u2019 navigation system Pintuition provides surgeons with real-time distance and directional navigational guidance to locate tumors easily and accurately. With over 100 active centers and over 5,000 successful Pintuition procedures across Western Europe and the US, the company experienced growth in revenue in 2022.<\/p>\n\n\n\n
\u201cSirius Medical has done a great job developing and bringing to market the Pintuition technology with a strong commercial start\u201d, says Peter Stein, Chief Executive of Norgine Ventures. \u201cNorgine Ventures is excited to support Sirius Medical\u2019s leadership and their vision to deliver cost-effective solutions in surgery.\u201d<\/p>\n\n\n\n
\u201cWe are excited about the market potential for surgical marker navigation,\u201d says Jan Frens van Giessel, partner at Holland Capital. \u201cWe believe that the Pintuition technology and its future innovations will significantly improve surgery of non-palpable tumors for patients, physicians and improve the care for cancer patients.\u201d <\/p>\n\n\n\n
\u201cHaving become the fastest growing company in the industry is a clear confirmation of the benefits that our technology brings to both patients and physicians,\u201d says Bram Schermers, CEO at Sirius Medical. \u201cSupported by this latest funding round, I am confident that our team will further drive the adoption of Pintuition across the globe.\u201d<\/p>\n\n\n